All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Simultaneous spectroscopic estimation of ezetimibe and simvastatin in tablet dosage forms

Author(s): SJ Rajput1, HA Raj2
1 Department of Pharmacy , Pharmaceutical Quality Assurance Laboratory, Faculty of Technology & Engineering, M. S. University of Baroda, Vadodara - 390 001, India 2 Department of Quality Assurance, Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana - 384 001, India

Correspondence Address:
H A Raj Department of Quality Assurance, Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana - 384 001 India E-mail: [email protected]


A simple, accurate and precise spectroscopic method was developed for simultaneous estimation of ezetimibe and simvastatin in tablets using first order derivative zero-crossing method. Ezetimibe showed zero crossing point at 245.4 nm while simvastatin showed zero crossing point at 265.2 nm. The dA/dl was measured at 265.2 nm for ezetimibe and 245.4nm for simvastatin and calibration curves were plotted as dA/dl versus concentration, respectively. The method was found to be linear (r 2 >0.9994) in the range of 5-40 µg/ml for ezetimibe at 265.20 nm. The linear correlation was obtained (r 2 >0.9935) in the range of 5-80 µg/ml for simvastatin at 245.4 nm. The limit of determination was 0.39 and 0.12 µg/ml for ezetimibe and simvastatin, respectively. The limit of quantification was 1.10 and 0.4 µg/ml for ezetimibe and simvastatin, respectively. The method was successfully applied for simultaneous determination of ezetimibe and simvastatin in binary mixture.



Share this